NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球影像診斷市場

Diagnostic Imaging

出版商 Global Industry Analysts, Inc. 商品編碼 903056
出版日期 內容資訊 英文 537 Pages
商品交期: 最快1-2個工作天內
價格
全球影像診斷市場 Diagnostic Imaging
出版日期: 2021年04月01日內容資訊: 英文 537 Pages
簡介

本報告提供全球影像診斷市場的相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業等相關資訊。

第1章 調查方法

第2章 摘要整理

  • 市場概要
    • 影像診斷市場踏實成長
    • 全球競爭企業市場佔有率
    • 全球市場佔有率方案
    • 各分類市場佔有率
    • 核子醫學攝影
    • CT
    • MRI
    • 超音波
    • X腺
  • 關注企業
  • 市場趨勢和促進因素
    • 高齡化
    • 心血管疾病,癌症,慢性疾病的發病率上升
    • 美國的癌症統計
    • MRI系統壟斷市場
    • 混合PET/MRI
    • 醫療用X光系統
    • CT掃描市場
    • 技術創新
    • 許多非放射科醫師進行診斷測試
    • AI醫療用影像的進步
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 中東
  • 伊朗
  • 以色列
  • 阿拉伯聯合大公國
  • 非洲

第4章 競爭

  • CARESTREAM HEALTH
  • ESAOTE SPA
  • FUJIFILM Holdings株式會社
  • HITACHI LTD.
  • KONINKLIJKE PHILIPS NV
  • SAMSUNG MEDISON
  • 株式會社島津製作所
  • SIEMENS HEALTHINEERS
  • 東芝MedicalSystems株式會社

第5章 相關調查

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP11515

Abstract:

The global market for Diagnostic Imaging is projected to reach US$31.8 billion by 2025, driven by the importance of medical imaging in healthcare in disease prevention, early detection, diagnosis, and treatment. Essential in the management of all virtually all medical conditions and diseases, there is growing interest in R&D of newer and more powerful imaging technologies. Advanced imaging capabilities provide huge benefits such as early detection; better diagnosis; detailed visualization of anatomical structures; easy and faster physician understanding of disease complications; better clinical decisions; reduced risk of errors; safer in terms of medical radiation exposure; and better patient outcome. Demand for diagnostic imaging services is poised to benefit from the growing global burden of disease which is directly linked to increasing life expectancy. With the average human living longer due to improvements in acute care, the risk of developing chronic diseases remains high leading to higher number of years lived with disability. Medications that slow progress of disease and prevent death such as BP, cholesterol drugs for cardiovascular diseases and new generation drugs for diabetics are responsible for the rise in life expectancy. For instance, drugs like Metformin has significantly increased survival rate in patients with diabetes and comorbid heart diseases. However, prolonged life with chronic diabetes leads to other diabetes-related health problems such as damage to eyes, kidneys, feet, nerves, large blood vessels of the heart, brain and legs. Higher number of years lived in less-than-ideal health pushes up demand for healthcare services. With medical imaging being the starting point for timely care and treatment, diagnostic imaging is the chief beneficiary of the aging population living with chronic diseases.

Popular diagnostic imaging technologies currently in use include X-rays, CT scan (computed tomography scan), MRI (magnetic resonance imaging), ultrasound, nuclear medicine imaging, including positron-emission tomography (PET), and optical imaging. The field of diagnostic imaging is effervescent and continuously evolving and changing with significant funds for R&D being continuously injected to develop more advanced imaging technologies that provide accurate and precise diagnosis. Few of the ongoing innovations include hybrid imaging technology that combines PET/CT, PET/MRI and/or SPECT/CT systems; development of imaging systems with lower doses of ionizing radiation or non-ionizing radiation such as Optical Coherence Tomography (OCT), Photoacoustic Imaging, Diffuse Optical Tomography (DOT), Raman Spectroscopy & Photoactivated Localization Microscopy (PALM), Florescence Imaging, Near-infrared fluorescence imaging, Bioluminescent Imaging (BLI); use of contrast Agents in diagnostic imaging; development of cryogen-free MRI imaging systems and automated CT scanners, among others. Nuclear imaging market is especially poised to grow supported by the epidemic spread of cancer. Nuclear medicine is an evolving area of radiology that utilizes tiny amounts of radioactive dye (tracer) to highlight damaged or infected tissues and cancer cells. Types of nuclear imaging modalities that utilize radioisotopes include bone density scan, Cardiac PET perfusion, Cardiac PET sarcoid, Cardiac SPECT perfusion, Cardiac PET viability, PET/CT scanning, MIBG (metaiodobenzylguanidine) scans, gallium scan, and SPECT. Nuclear imaging equipment, over the decades, has witnessed several advances at the technological front. Technological advances continue to drive the market, with some of these focusing in improving systems in order to enhance clinical decision-making for clinicians as well as patients. Rising density of diagnostic imaging units is resulting in growing number of imaging procedures performed each day. CT & MRI scans dominate the diagnostic radiology industry, with the United States leading the world in terms of volume of procedures performed. The United States and Europe represent large markets worldwide with a combined share of 59% of the market. China ranks as the fastest growing market with a CAGR of 7.6% over the analysis period supported by the country's rapidly developing healthcare system under the "Healthy China 2020" initiative which is largely focused on chronic disease prevention.

Select Competitors (Total 66 Featured) -

  • Carestream Health, Inc.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Diagnostic Imaging - A Prelude
    • Global Diagnostic Imaging Market Set for a Strong Growth
    • Developed Regions: The Dominant Markets for Diagnostic Imaging
    • Developing Regions Exhibit the Fastest Growth
    • Increase in Number of Hospitals & Clinics Infuses Momentum in Developing Regions
    • Key Players
    • Segment Analysis
    • MRI Dominates the Global Diagnostic Imaging Market
    • EXHIBIT 1: Equipment Density Correlates With Number of Imaging Procedures: Magnetic Resonance Imaging (MRI) Units in Select Countries (Per Million Population) for the Year 2019
    • Global MRI Market by Application (2019): Percentage Breakdown of Procedure Volume for Brain, Cardiac & Vascular, Extremities, Full Body, Mammography, Spine and Others
    • Computed Tomography System (CT Scanner)
    • Ultrasound
    • EXHIBIT 2: Global Ultrasound Systems Market by Portability Type (2019): Percentage Breakdown of Unit Sales for Cart Systems and Point-of Care Systems
    • X-Ray
    • Nuclear Medicine
    • SPECT Dominates the Nuclear Medicine Market
    • Worldwide Installed Base of Nuclear Imaging Equipment by Modality (2019): Percentage Breakdown of Units Installed for PET and SPECT
  • PET
  • 2. FOCUS ON SELECT PLAYERS
    • Agfa-Gevaert N.V. (Belgium
    • Canon Medical Systems Corporation (Japan)
    • Carestream Health, Inc. (USA)
    • Esaote S.p.A. (Italy)
    • Fujifilm Corporation (Japan)
    • GE Healthcare (UK)
    • Koninklijke Philips N.V. (Netherlands)
    • Konica Minolta Inc. (Japan)
    • Hitachi Ltd. (Japan)
    • Hologic, Inc. (USA)
    • HOYA Group Pentax (Japan)
    • Samsung Medison Co., Ltd. (Korea)
    • Shimadzu Corporation (Japan)
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China
    • Siemens Healthineers (Germany)
  • 3. MARKET TRENDS & DRIVERS
    • Rapidly Growing Geriatric Population and the Rise in Associated Diseases Catalyze Growth
    • Rapidly Aging Population Spurs Demand for Diagnostic Imaging: Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020, 2025, 2030 & 2050
    • Rising Incidence of Chronic Diseases Propels the Demand for Medical Imaging
    • Rising Prevalence of Chronic Diseases Amplifies the Volume of Diagnostic Imaging Procedures: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Growing Emphasis on Early Diagnosis is a Driving Factor for Diagnostic Imaging
    • Rising Healthcare Expenditure Impels Global Market
    • Oncology Diagnostic Imaging to Witness Rapid Growth
    • Global Cancer Incidence by Type: 2018
    • Technological Innovations Drive the Global Diagnostic Imaging Market
    • Growing Adoption of Hybrid Diagnostic Imaging Modalities
    • PET-CT: The Most Successful Fusion Imaging Technique
  • SPECT-CT
    • PET/MRI Continues to Makes Inroads
    • Ultrasound and MRI Imaging: An Efficient Combination
    • Rapid Adoption of Contrast-Enhanced Ultrasound (CEUS) Drives Market Growth
    • CT Imaging Gains Popularity
    • CCTA Gaining Traction in Coronary Arteries Imaging
  • USE OF BLOCKCHAIN IN DIAGNOSTIC IMAGING
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for X-ray Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for X-ray Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for X-ray Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 37: Canada Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 40: Japan Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 43: Japan Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 46: China Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 49: China Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: China Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: China 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 52: Europe Current & Future Analysis for Diagnostic Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Diagnostic Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 58: Europe Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Europe Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Europe 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 61: France Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 64: France Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: France Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: France 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 67: Germany Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 70: Germany Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Germany Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Germany 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 73: Italy Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 76: Italy Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Italy Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: Italy 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 79: UK Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 82: UK Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: UK Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: UK 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 85: Spain Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Spain Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Spain 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 88: Spain Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Spain Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Spain 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 91: Russia Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Russia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Russia 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 94: Russia Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Russia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Russia 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 97: Rest of Europe Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of Europe Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of Europe 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 100: Rest of Europe Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Rest of Europe Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Rest of Europe 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 103: Asia-Pacific Current & Future Analysis for Diagnostic Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 104: Asia-Pacific Historic Review for Diagnostic Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: Asia-Pacific 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 106: Asia-Pacific Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Asia-Pacific Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: Asia-Pacific 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 109: Asia-Pacific Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Asia-Pacific Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Asia-Pacific 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 112: Australia Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Australia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: Australia 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 115: Australia Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Australia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: Australia 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 118: India Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: India Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: India 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 121: India Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: India Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: India 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 124: South Korea Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 125: South Korea Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 126: South Korea 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 127: South Korea Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: South Korea Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 129: South Korea 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 130: Rest of Asia-Pacific Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Asia-Pacific Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of Asia-Pacific Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Asia-Pacific Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Asia-Pacific 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 136: Latin America Current & Future Analysis for Diagnostic Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 137: Latin America Historic Review for Diagnostic Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 138: Latin America 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 139: Latin America Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Latin America Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 141: Latin America 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 142: Latin America Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Latin America Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 144: Latin America 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 145: Argentina Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Argentina Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 147: Argentina 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 148: Argentina Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Argentina Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 150: Argentina 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 151: Brazil Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Brazil Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 153: Brazil 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 154: Brazil Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Brazil Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 156: Brazil 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 157: Mexico Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Mexico Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 159: Mexico 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 160: Mexico Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Mexico Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 162: Mexico 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 163: Rest of Latin America Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Rest of Latin America Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 165: Rest of Latin America 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 166: Rest of Latin America Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Rest of Latin America Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 168: Rest of Latin America 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 169: Middle East Current & Future Analysis for Diagnostic Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 170: Middle East Historic Review for Diagnostic Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 171: Middle East 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 172: Middle East Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Middle East Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 174: Middle East 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 175: Middle East Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Middle East Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 177: Middle East 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 178: Iran Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Iran Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 180: Iran 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 181: Iran Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Iran Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 183: Iran 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 184: Israel Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Israel Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 186: Israel 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 187: Israel Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Israel Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 189: Israel 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 190: Saudi Arabia Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Saudi Arabia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 192: Saudi Arabia 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 193: Saudi Arabia Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Saudi Arabia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 195: Saudi Arabia 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 196: UAE Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 197: UAE Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 198: UAE 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 199: UAE Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 200: UAE Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 201: UAE 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 202: Rest of Middle East Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Rest of Middle East Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 204: Rest of Middle East 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 205: Rest of Middle East Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Rest of Middle East Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 207: Rest of Middle East 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 208: Africa Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Africa Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 210: Africa 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 211: Africa Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Africa Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 213: Africa 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 66